nausea and vomiting. Nausea and vomiting
Conditions
Interventions
Intervention 1: First intervention group: Patients in this group received 2 mg of Granisetron (in a total volume of 10 ml), 5 minutes before induction of anesthesia. Intervention 2: Second interventio
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with ASA grade one Patients with ASA grade two Patient were referred for laparoscopic cholecystectomy
Exclusion criteria
Exclusion criteria: Febrile illness History of infection Pulmonary disease Allergy to Endonestrone Allergy to Granisetron History of seizure History of vascular contraction Intracranial pressure History of drug abuse Patients who do not have proper collaboration during the study History of digestive disease Emergency patients Patients with a history of motion sickness (PTSD) or motion sickness (PONV) have a history of nausea and vomiting Surgery Patients with history of nausea and vomiting during previous surgery Patients who received anti-nausea and vomiting before surgery Patients with hypothermia (below 36 ° C) Pregnancy Inability to perceive VAS criteria for pain The patient's consent for participation in the study Weight more than 120kg Weight less than 50kg
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: Patients were monitored for nausea and vomiting during recovery and after recovery for 24 hours during the hours (2-4-6-12-24). Method of measurement: According to Clinical Obstetrician Anesthesiologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaid Kashani
Bandare-abbas University of Medical Sciences
Outcome results
None listed